Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

South African hitman dies of brain tumor, was due to testify in Briton's murder trial

Published 10/19/2014, 05:52 AM
Updated 10/19/2014, 06:00 AM
© Reuters Honeymoon murder accused Shrien Dewani sits in the dock before the start of his trial in Cape Town

JOHANNESBURG (Reuters) - A South African hitman serving a life sentence for shooting dead the wife of British businessman Shrien Dewani has died of a brain tumor, the justice minister said, before he was due to testify in Dewani's trial for plotting the murder.

Xolilie Mngeni, 27, was diagnosed with having a brain tumor in 2011, shortly after being convicted of firing the shot that killed Anni Dewani while she was on honeymoon in South Africa.

He died in the hospital section of Goodwood Correctional Centre in Cape Town as his application for medical parole was rejected by Justice Minister Michael Masutha in June.

Mngeni was set to testify in Dewani's trial which is underway at the Western Cape High Court.

Shrien Dewani has denied all charges of conspiring to kill his wife in Cape Town in November 2010. Three South Africans, including Mngeni, had already been serving jail terms for her murder.

Dewani lost a three-year legal battle in Britain to avoid being extradited to and tried in South Africa.

Last Monday, he told the court he was bisexual, apparently a response to British media speculation that he engineered his wife's murder to escape a heterosexual relationship.

(Reporting By Mfuneko Toyana; Editing by Raissa Kasolowsky)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.